Area of Focus: Immunology

Oragen Therapeutics is a biotech start-up developing a patented oral RNA delivery platform for intestinal diseases, initially targeting Inflammatory Bowel Diseases. Our proprietary encapsulation technology enables targeted RNA release in inflamed gut tissue, improving adherence, safety, and potency. We operate a dual business model, combining drug development and technology licensing, to de-risk our profile and maximize value creation.